Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Growth Slows In Medicare Payments For Advanced Imaging, Study Finds

This article was originally published in The Gray Sheet

Executive Summary

A coalition of manufacturers, radiologists and patient groups is urging policy-makers to reconsider ongoing cuts in Medicare payments for medical imaging, based on signs that the growth in volume and spending for advanced medical imaging has slowed for the first time in more than a decade.

You may also be interested in...



MedPAC Forwards More Ideas To Reduce Advanced Imaging Spending

The Medicare Payment Advisory Commission outlined four draft recommendations last week intended to either reduce payments for or control use of advanced imaging tools. Among the ideas: a prior authorization program specifically targeting physicians who order the most imaging scans.

MedPAC Forwards More Ideas To Reduce Advanced Imaging Spending

The Medicare Payment Advisory Commission outlined four draft recommendations last week intended to either reduce payments for or control use of advanced imaging tools. Among the ideas: a prior authorization program specifically targeting physicians who order the most imaging scans.

MedPAC Looks At Options To Control Volume Of In-Office Ancillary Services

The Medicare Payment Advisory Commission is examining ways CMS might reduce spending on radiation therapy treatments, diagnostic imaging and laboratory tests charged by self-referring physicians

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT029849

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel